Effects of Empagliflozin and Dapagliflozin on Lipid Profiles and Atherogenic Risk Indices in Patients with Heart Failure and a History of CABG: First Evidence in the Literature.
Saved in:
| Title: | Effects of Empagliflozin and Dapagliflozin on Lipid Profiles and Atherogenic Risk Indices in Patients with Heart Failure and a History of CABG: First Evidence in the Literature. |
|---|---|
| Authors: | Ozgol, Ilhan1 (AUTHOR) ilhanozgol@gmail.com, Yigit Gencer, Ece2 (AUTHOR), Yildiz, Cennet3 (AUTHOR), Karabulut, Dilay3,4 (AUTHOR), Turhan Çaglar, Fatma Nihan3,5 (AUTHOR), Bicakhan, Burcu4,6 (AUTHOR), Yucel, Cihan1 (AUTHOR), Ketenciler, Serkan1,2 (AUTHOR), Ay, Asime3,5 (AUTHOR), Yigit, Zerrin4,6 (AUTHOR) |
| Source: | Journal of Clinical Medicine. Oct2025, Vol. 14 Issue 20, p7395. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20770383 |
|---|---|
| DOI: | 10.3390/jcm14207395 |
